Bone drug takes aim at hidden HIV
NCT ID NCT07216794
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study tests whether alendronate, a drug used for bone health, can reduce the amount of hidden HIV in people who are already on standard HIV treatment. About 30 participants will be randomly assigned to receive either alendronate or a placebo, and neither they nor their doctors will know which they received. The goal is to see if this approach can shrink the HIV reservoir, which is the main barrier to controlling the virus long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chapel Hill (Site ID: 3201)
Chapel Hill, North Carolina, 27599, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ohio State University (Site ID: 2301)
Columbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California, San Francisco HIV/AIDS (Site ID: 801)
San Francisco, California, 94110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Colorado Hospital (Site ID: 6101)
Aurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh (Site ID: 1001)
Pittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.